We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy
EP39379
Abstract: CD Genomics aims at providing the research community with Illumina, PacBio SMRT and Nanopore platforms, and bioinformatics services. The utilization of real-time, long-read sequencing overcomes the challenges associated with traditional short-read sequencing technologies, to fully characterize microbial genomes - sheds new light on microbial evolution, pathogenicity, and antimicrobial resistance. Summary: As a leading genomics company, CD Genomics provides next-generation sequencing and bioinformatics services to pharmaceutical and biotech companies, as well as academic and government agencies around the world, relying on advanced sequencing instruments and rich project experience. References: https://longseq.cd-genomics.com/pacbio-smrt-sequencing-technology.html
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Related Posters
Data Analysis of 16S/18S/ITS Amplicon Sequencing Results
CD Genomics
Abstract 23: Precision medicine approaches to Fanconi anemia oral cancer personalized prevention and treatment
Daniel K. Swenson; Beverly R. Wuertz; Mustafa M. Ali; Gretchen M. Unger; Frank G. Ondrey
Genomic analysis points to changes in markers of stemness in oral cancer progression
Gretchen M. Unger, Beverly R. Wuertz, Patrick M. Gaffney, Frank G. Ondrey.
Potential roles for fibrosis and changing metabolism in oral preneoplasia progression
Gretchen Unger, Beverly Wuertz, Charles Pruett, Matthew Watkins, Pat Gaffney, Frank Ondrey
Rapid Review on Novel Corona Virus
Saurav Suryavanshi
